Literature DB >> 16943169

Vascular cognitive impairment.

John T O'Brien1.   

Abstract

Cerebrovascular disease is increasingly recognized as a common cause of cognitive impairment and dementia in later life either alone or in conjunction with other pathologies, most often Alzheimer disease (AD). Progress in the field has been limited by difficulties in terminology; for example, use of the term dementia necessitates the presence of memory impairment, which is the norm in AD, but not in cognitive disorders associated with cerebrovascular disease. The term vascular cognitive impairment (VCI) has been proposed as an umbrella term to recognize the broad spectrum of cognitive, and indeed behavioral, changes associated with vascular pathology. It is characterized by a specific cognitive profile with predominantly attentional and executive impairments together with particular noncognitive features (especially depression) and a relatively stable course, at least in clinical trial populations. Subtypes of VCI have been proposed based on clinical and pathologic differences, including cortical, subcortical, strategic infarct, hypoperfusion, hemorrhagic, and mixed (with AD) type. Diagnostic criteria are emerging but require refinement and validation, especially for mixed dementias. There remain fundamental gaps in our understanding of pathophysiology, predicting prognosis and outcome, and in therapeutics. Clinical trials to date, mainly in populations selected using currently accepted criteria for vascular dementia, have generally been disappointing. A relatively modest cognitive benefit of agents such as nimodipine, memantine, and cholinesterase inhibitors has been reported, although the clinical significance of these improvements remains to be established. Further studies, focusing on particular subtypes of VCI and involving subjects at earlier stages of the disease, are required. The aim of this article is to review the concept of VCI in terms of the evidence base surrounding diagnosis, clinical features, pathophysiology, and management and to make some recommendations regarding further research in the area. It begins with a discussion on the historical background, which is important to understand the different and somewhat confusing terminology that currently exists in the field.

Entities:  

Mesh:

Year:  2006        PMID: 16943169     DOI: 10.1097/01.JGP.0000231780.44684.7e

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  65 in total

1.  An exploration of subgroups of mild cognitive impairment based on cognitive, neuropsychiatric and functional features: analysis of data from the National Alzheimer's Coordinating Center.

Authors:  John J Hanfelt; Joanne Wuu; Ann B Sollinger; Melanie C Greenaway; James J Lah; Allan I Levey; Felicia C Goldstein
Journal:  Am J Geriatr Psychiatry       Date:  2011-11       Impact factor: 4.105

2.  In vivo two-photon excited fluorescence microscopy reveals cardiac- and respiration-dependent pulsatile blood flow in cortical blood vessels in mice.

Authors:  Thom P Santisakultarm; Nathan R Cornelius; Nozomi Nishimura; Andrew I Schafer; Richard T Silver; Peter C Doerschuk; William L Olbricht; Chris B Schaffer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-20       Impact factor: 4.733

3.  Cognitive profiles in heart failure: a cluster analytic approach.

Authors:  Lindsay A Miller; Mary Beth Spitznagel; Michael L Alosco; Ronald A Cohen; Naftali Raz; Lawrence H Sweet; Lisa Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  J Clin Exp Neuropsychol       Date:  2012-03-01       Impact factor: 2.475

Review 4.  Vascular aspects of cognitive impairment and dementia.

Authors:  Maximilian Wiesmann; Amanda J Kiliaan; Jurgen A H R Claassen
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-11       Impact factor: 6.200

5.  Potential beneficial effects of low molecular weight heparin on cognitive impairment in elderly patients on haemodialysis.

Authors:  Milenka Sain; Vedran Kovacic; Josipa Radic; Dragan Ljutic; Ivo Jelicic
Journal:  Drugs Aging       Date:  2012-01-01       Impact factor: 3.923

6.  Cognitive Associates of Current and More Intensive Control of Hypertension: Findings From the Hispanic Community Health Study/Study of Latinos.

Authors:  Melissa Lamar; Donghong Wu; Ramon A Durazo-Arvizu; Adam M Brickman; Hector M Gonzalez; Wassim Tarraf; Martha L Daviglus
Journal:  Am J Hypertens       Date:  2017-06-01       Impact factor: 2.689

7.  Outcomes of older cognitively impaired individuals with current and past depression in the NCODE study.

Authors:  David C Steffens; Douglas R McQuoid; Guy G Potter
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-02-04       Impact factor: 2.680

Review 8.  Huperzine A for vascular dementia.

Authors:  Zilong Hao; Ming Liu; Zhiqin Liu; Donghao Lv
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

Review 9.  Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

Authors:  Efrat Kravitz; James Schmeidler; Michal Schnaider Beeri
Journal:  Endocrinol Metab Clin North Am       Date:  2013-09       Impact factor: 4.741

10.  Longitudinal relationships between cognitive functioning and depressive symptoms among Hispanic older adults.

Authors:  Tatiana Perrino; Craig A Mason; Scott C Brown; Arnold Spokane; José Szapocznik
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2008-09       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.